Angiodynamics (ANGO) Enterprise Value (2010 - 2026)
Angiodynamics' (ANGO) quarterly Enterprise Value came in at -$53.9 million in Q2 2026, up 3.63% YoY from -$52.0 million in Q2 2025, and down 42.46% on a QoQ basis from -$37.8 million in Q1 2026.
Angiodynamics (ANGO) Enterprise Value (2010 - 2026) Analysis & Trends
Angiodynamics (ANGO) has 17 years of Enterprise Value data on file, last reported at -$53.9 million in Q2 2026.
- Quarterly Enterprise Value rose 3.63% year-over-year to -$53.9 million in Q2 2026, while the trailing twelve-month figure through May 2026 was -$53.9 million (up 3.63% YoY) and the FY2026 annual result came in at -$53.9 million, up 3.63% from the prior year.
- Enterprise Value declined to -$53.9 million in Q2 2026, from -$37.8 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$23.9 million in Q1 2022 to a low of -$78.5 million in Q1 2024.
- A 5-year average of -$46.5 million and a median of -$44.7 million in 2023 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value soared 56.14% — and 2024, when it sank 160.54%.
- Tracing ANGO's Enterprise Value over 5 years: stood at -$29.9 million in 2022, then slumped by 103.96% to -$60.9 million in 2023, then climbed by 11.18% to -$54.1 million in 2024, then climbed by 23.02% to -$41.6 million in 2025, then declined by 29.36% to -$53.9 million in 2026.
- The last three Enterprise Value figures came in at -$53.9 million (Q2 2026), -$37.8 million (Q1 2026), and -$41.6 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 135.11 Bn | 129.89 Bn | 1.96 Bn | -5.09 Bn |
| 2 | Becton Dickinson | 52.56 Bn | 51.69 Bn | 2.32 Bn | -863.00 Mn |
| 3 | Alcon | 35.75 Bn | 34.40 Bn | 1.68 Bn | -1.36 Bn |
| 4 | Resmed | 34.02 Bn | 32.55 Bn | 861.22 Mn | -1.47 Bn |
| 5 | Medline | 29.09 Bn | 26.41 Bn | 2.22 Bn | 4.83 Bn |
| 6 | West Pharmaceutical Services | 24.92 Bn | 24.49 Bn | 329.20 Mn | -435.80 Mn |
| 7 | Solventum | 15.30 Bn | 14.90 Bn | 1.29 Bn | -403.00 Mn |
| 8 | Cooper Companies | 14.83 Bn | 14.69 Bn | 735.40 Mn | -138.60 Mn |
| 9 | Baxter International | 13.66 Bn | 11.51 Bn | 1.03 Bn | -2.18 Bn |
| 10 | Angiodynamics | 652.37 Mn | 598.51 Mn | 46.77 Mn | -53.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -53.86 Mn |
| Feb 28, 2026 | -37.81 Mn |
| Nov 30, 2025 | -41.64 Mn |
| Aug 31, 2025 | -38.76 Mn |
| May 31, 2025 | -55.89 Mn |
| Feb 28, 2025 | -44.76 Mn |
| Nov 30, 2024 | -54.09 Mn |
| Aug 31, 2024 | -55.01 Mn |
| May 31, 2024 | -76.06 Mn |
| Feb 29, 2024 | -78.45 Mn |
| Nov 30, 2023 | -60.90 Mn |
| Aug 31, 2023 | -57.59 Mn |
| May 31, 2023 | -44.62 Mn |
| Feb 28, 2023 | -30.11 Mn |
| Nov 30, 2022 | -29.86 Mn |
| Aug 31, 2022 | -24.56 Mn |
| May 31, 2022 | -28.83 Mn |
| Feb 28, 2022 | -23.89 Mn |
| Nov 30, 2021 | -34.29 Mn |
| Aug 31, 2021 | -35.47 Mn |